Patent ID: 9603857
Date: 2017-03-28
CPC Classifications: A61K

Claim:
1. A method of treating non-specific interstitial pneumonitis in a patient comprising the steps of: (i) confirming that the patient's C-Reactive Protein (CRP) concentration in the blood is 3 mg/l or more; (ii) stabilizing the patient's symptoms with prednisone, azathioprine, and N-Acetyl Cysteine; (iii) stepping down the prednisone and azathioprine drug doses incrementally; (iv) stabilizing the patient's symptoms and inflammation after each step down of the prednisone and azathioprine drug doses using a non-toxic therapy wherein the non-toxic therapy is selected from the group consisting of aerobic exercise and resistance exercise; and (v) continuing said incremental stepping down of the prednisone and azathioprine drug doses using said non-toxic therapy until the inflammation is reduced to a CRP value of below 3 mg/l.